Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.

Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van Waes C.

Cancer Res. 2004 Sep 15;64(18):6511-23. Erratum in: Cancer Res. 2004 Nov 1;64(21):8130-2.

2.

NF-kappaB: tumor promoter or suppressor?

Perkins ND.

Trends Cell Biol. 2004 Feb;14(2):64-9. Review.

PMID:
15102437
3.

Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.

Allen CT, Ricker JL, Chen Z, Van Waes C.

Head Neck. 2007 Oct;29(10):959-71. Review.

PMID:
17405170
4.

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

Suh J, Rabson AB.

J Cell Biochem. 2004 Jan 1;91(1):100-17. Review.

PMID:
14689584
5.

NF-kappaB as a therapeutic target in cancer.

Orlowski RZ, Baldwin AS Jr.

Trends Mol Med. 2002 Aug;8(8):385-9. Review.

PMID:
12127724
6.

Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.

Bowden GT, Schneider B, Domann R, Kulesz-Martin M.

Cancer Res. 1994 Apr 1;54(7 Suppl):1882s-1885s. Review.

7.

Molecular carcinogenesis of squamous cell carcinomas of the skin.

Kubo Y, Murao K, Matsumoto K, Arase S.

J Med Invest. 2002 Aug;49(3-4):111-7. Review.

PMID:
12322999
8.
9.

Regulation of NF-kappaB by oncoproteins and tumor suppressor proteins.

Madrid LV, Baldwin AS Jr.

Methods Mol Biol. 2003;223:523-32. Review. No abstract available.

PMID:
12777748
10.

Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotype.

Marini AM, Jiang X, Wu X, Tian F, Zhu D, Okagaki P, Lipsky RH.

Restor Neurol Neurosci. 2004;22(2):121-30. Review.

PMID:
15272146
11.

The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis.

de Martin R, Schmid JA, Hofer-Warbinek R.

Mutat Res. 1999 Nov;437(3):231-43. Review.

PMID:
10592330
12.
13.

Regulation of cyclin D1 gene expression.

Witzel II, Koh LF, Perkins ND.

Biochem Soc Trans. 2010 Feb;38(Pt 1):217-22. doi: 10.1042/BST0380217. Review.

PMID:
20074063
14.

[The tumor suppressor gene p53 and its significance for dermatology].

Lübbe J, Kleihues P, Burg G.

Hautarzt. 1994 Nov;45(11):741-5. Review. German.

PMID:
7822196
15.

Nuclear factor-kappaB: a friend or a foe in cancer?

Shishodia S, Aggarwal BB.

Biochem Pharmacol. 2004 Sep 15;68(6):1071-80. Review.

PMID:
15313403
16.

Oral cancer in the molecular age.

Regezi JA, Jordan RC.

J Calif Dent Assoc. 2001 Aug;29(8):578-84. Review.

PMID:
11577668
17.

Role of Rho-family proteins in cell adhesion and cancer.

Malliri A, Collard JG.

Curr Opin Cell Biol. 2003 Oct;15(5):583-9. Review.

PMID:
14519393
18.
20.

NF-kappaB signaling pathway, inflammation and colorectal cancer.

Wang S, Liu Z, Wang L, Zhang X.

Cell Mol Immunol. 2009 Oct;6(5):327-34. doi: 10.1038/cmi.2009.43. Review.

Supplemental Content

Support Center